UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Carbamazepine Essential Pharma 250 mg Suppositorium
- Scientific Name Part: Name
- Strength part: 250 mg
- Pharmaceutical dose form part: Suppositorium
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Suppository
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 11830
Region: Kingdom of Sweden
Marketing authorisation holder: Essential Pharma (M) Ltd
Identifier:
Status: Valid (1993-05-07)
Package 1 of 1
PCID:
Description: Strip, 5 suppositorier
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 1 Strip (PolyPropylene) (Aluminium) (PolyEthylene)
Containing: 5 Suppository
Manufactured Item
Dose form: Suppository
Unit of presentation: Suppository
Ingredient
Role: Active
Substance: Carbamazepine
Presentation strength: 250 milligram(s) / 1 Suppository
Reference strength: Carbamazepine 250 milligram(s) / 1 Suppository